TY - JOUR AU - Aravot, Dan AU - Barac, Yaron D. AU - Krutzwald-Josefson, Efrat AU - Allen, Aaron M. AU - Flex, Dov AU - Peled, Nir AU - Kramer, Mordechai R. AU - Peysakhovich, Yuri AU - Saute, Milton PY - 2019 DA - 2019/01/09 TI - Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity JO - Journal of Cardiothoracic Surgery SP - 7 VL - 14 IS - 1 AB - Advanced non-small cell lung cancer (NSCLC) is still a therapeutic challenge as the 5-year survival is under 30%. The optimal treatment regimen is still under debate. SN - 1749-8090 UR - https://doi.org/10.1186/s13019-018-0829-z DO - 10.1186/s13019-018-0829-z ID - Aravot2019 ER -